Patel Gautam — SEC insider filings
SEC reporting owner CIK 1738054. 27 insider filings on record with FilingPulse; latest filed 2026-10-05.
Transaction summary — filings shown
Covers all 27 filings on record, filed 2020-12-23 to 2026-10-05. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): 1 leg across 1 filing — 50,000 shares, $210,500 total (shares × price as filed).
- Open-market sales (code S, non-derivative): 9 legs across 8 filings — 480,000 shares, $3,951,027 total (shares × price as filed).
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 30.
- Largest priced transaction: sale of 94,906 shares @ $8.02 ($761,146) in Amneal Pharmaceuticals, Inc., filed 2025-06-18.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| Amneal Pharmaceuticals, Inc. (AMRX) | Director | 20 | 1 leg · 50,000 sh · $210,500 | 9 legs · 480,000 sh · $3,951,027 | 24 |
| Spectrum Brands Holdings, Inc. (SPB) | Director | 6 | — | — | 6 |
| ANAVEX LIFE SCIENCES CORP. (AVXL) | Director | 1 | — | — | — |
Insider filings — Patel Gautam
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-10-05 | 3 | ANAVEX LIFE SCIENCES CORP. (AVXL) | Holdings only — no transactions reported | EDGAR |
| 2026-08-12 | 4 | Amneal Pharmaceuticals, Inc. (AMRX) | Grant/award (A): 283,632 | EDGAR |
| 2026-05-08 | 4 | Amneal Pharmaceuticals, Inc. (AMRX) | Option exercise (M): 34,819 · Option exercise (M): 34,819 (derivative) @ $0 · Grant/award (A): 19,824 (derivative) @ $0 | EDGAR |
| 2025-12-16 | 4 | Spectrum Brands Holdings, Inc. (SPB) | Grant/award (A): 4,602 @ $0 | EDGAR |
| 2025-06-18 | 4 | Amneal Pharmaceuticals, Inc. (AMRX) | Sale (S): 94,906 @ $8.02 | EDGAR |
| 2025-06-12 | 4 | Amneal Pharmaceuticals, Inc. (AMRX) | Sale (S): 56,426 @ $8.02 | EDGAR |
| 2025-05-08 | 4 | Amneal Pharmaceuticals, Inc. (AMRX) | Option exercise (M): 40,258 · Option exercise (M): 40,258 (derivative) @ $0 · Grant/award (A): 34,819 (derivative) @ $0 | EDGAR |
| 2025-05-06 | 4 | Amneal Pharmaceuticals, Inc. (AMRX) | Sale (S): 3,768 @ $8 · Sale (S): 4,900 @ $8 | EDGAR |
| 2025-04-02 | 4 | Amneal Pharmaceuticals, Inc. (AMRX) | Sale (S): 80,000 @ $8.30 | EDGAR |
| 2025-03-05 | 4 | Amneal Pharmaceuticals, Inc. (AMRX) | Sale (S): 80,000 @ $8.90 | EDGAR |
| 2025-02-05 | 4 | Amneal Pharmaceuticals, Inc. (AMRX) | Sale (S): 80,000 @ $8.14 | EDGAR |
| 2025-01-10 | 4 | Amneal Pharmaceuticals, Inc. (AMRX) | Sale (S): 62,590 @ $8.01 | EDGAR |
| 2025-01-06 | 4 | Amneal Pharmaceuticals, Inc. (AMRX) | Sale (S): 17,410 @ $8.01 | EDGAR |
| 2024-11-20 | 4 | Spectrum Brands Holdings, Inc. (SPB) | Grant/award (A): 2,770 @ $90.26 | EDGAR |
| 2024-05-14 | 4 | Amneal Pharmaceuticals, Inc. (AMRX) | Option exercise (M): 76,453 · Option exercise (M): 76,453 (derivative) @ $0 | EDGAR |
| 2024-05-06 | 4 | Amneal Pharmaceuticals, Inc. (AMRX) | Grant/award (A): 40,258 (derivative) @ $0 | EDGAR |
| 2024-01-03 | 4 | Amneal Pharmaceuticals, Inc. (AMRX) | Other (J): 33,458,067 · Gift (G): 1,598,115 @ $0 | EDGAR |
| 2023-12-01 | 4/A | Amneal Pharmaceuticals, Inc. (AMRX) | Other (J): 3,073,298 | EDGAR |
| 2023-11-28 | 4 | Spectrum Brands Holdings, Inc. (SPB) | Grant/award (A): 3,775 @ $0 | EDGAR |
| 2023-11-08 | 4 | Amneal Pharmaceuticals, Inc. (AMRX) | Other (J): 17,497,336 · Other (J): 17,497,336 (derivative) | EDGAR |
| 2023-05-11 | 4 | Amneal Pharmaceuticals, Inc. (AMRX) | Option exercise (M): 80,128 · Grant/award (A): 76,453 (derivative) @ $0 · Option exercise (M): 80,128 (derivative) @ $0 | EDGAR |
| 2022-11-29 | 4 | Spectrum Brands Holdings, Inc. (SPB) | Grant/award (A): 5,020 @ $0 | EDGAR |
| 2022-05-10 | 4 | Amneal Pharmaceuticals, Inc. (AMRX) | Option exercise (M): 35,406 · Option exercise (M): 35,406 (derivative) @ $0 · Grant/award (A): 80,128 (derivative) @ $0 | EDGAR |
| 2021-12-20 | 4 | Amneal Pharmaceuticals, Inc. (AMRX) | Purchase (P): 50,000 @ $4.21 | EDGAR |
| 2021-12-17 | 4 | Spectrum Brands Holdings, Inc. (SPB) | Grant/award (A): 2,441 @ $0 | EDGAR |
| 2021-05-07 | 4 | Amneal Pharmaceuticals, Inc. (AMRX) | Option exercise (M): 46,218 · Grant/award (A): 35,406 (derivative) @ $0 · Option exercise (M): 46,218 (derivative) @ $0 | EDGAR |
| 2020-12-23 | 4 | Spectrum Brands Holdings, Inc. (SPB) | Grant/award (A): 3,533 @ $0 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2020-12-17 and is expanding backward through EDGAR history; Forms 3 and 5 are covered live-forward since 2026-09-23 (no 3/5 history). Earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1738054 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. Get a free API key → · API docs